Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details 1)

v3.24.3
Stockholders' Equity (Details 1) - Twin Vee [Member] - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]      
Number of options outstanding at beginning of period 1,271,016 1,283,571 1,283,571
Weighted average exercise price at beginning of period $ 3.99 $ 4.14 $ 4.14
Weighted average remaining life (years) 8 years 8 months 19 days 8 years 2 months 15 days 8 years 11 months 12 days
Grant date fair value of options at beginning of period $ 2,213,147 $ 2,256,233 $ 2,256,233
Number of options, Granted 1,222,000 0  
Weighted average exercise price, Granted $ 0.61 $ 0  
Grant date fair value of options, Granted $ 550,352 $ 0  
Number of options, Exercised 0 0  
Weighted average exercise price, Exercised $ 0 $ 0  
Grant date fair value of options, Exercised $ 0    
Number of options, Expired (338,887) (44,394)  
Weighted average exercise price, Expired $ (3.87) $ (5.40)  
Grant date fair value of options, Expired $ (578,867) $ (101,960)  
Number of options, Forfeited/canceled (120,930) (25,000)  
Weighted average exercise price, Forfeited/canceled $ (2.97) $ 0  
Grant date fair value of options, Forfeited/canceled $ (153,829) $ 0  
Number of options outstanding at ending of period 2,033,199 1,214,177 1,271,016
Weighted average exercise price at ending of period $ 2.04 $ 4.13 $ 3.99
Grant date fair value of options at ending of period $ 2,030,803 $ 4,410,507 $ 2,213,147
Number of options, Exercisable options 773,614 821,100  
Weighted average exercise price, Exercisable options $ 4.16 $ 4.41  
Weighted average remaining life (years), Exercisable options 7 years 3 months 21 days 8 years 7 months 9 days  
Weighted average remaining life (years)     8 years 14 days